Hannah Joseph Hospital Ltd (HANNAH) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Hannah Joseph Hospital Ltd on NSE and BSE, with an AI summary of each filing.
Hannah Joseph Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve the Unaudited Financial ....
Intimation · 05 Nov 2026, 5:30 am
Hannah Joseph Hospital Schedules Board Meeting For Half-Year Financial Results Hannah Joseph Hospital Ltd announced that its Board of Directors is scheduled to meet on 5th Nov'26 to consider and approve the unaudited financial results alongside the Limited Review Report for the half year ended 30th Sep'26. In compliance with SEBI PIT Regulations, the trading window for dealing in company securities by insiders and designated persons has been closed effective 1st Oct'26 and will reopen 48 hours post the formal declaration of results.
Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 regarding Significant Milestones achieved by Hannah Jospeh Hospital in Advanced Neurovascular Care.
Press Release · 28 Oct 2026, 8:06 pm
Hannah Joseph Hospital Achieves Major Milestones in Advanced Neurovascular Procedures Hannah Joseph Hospital Limited reported three advanced clinical milestones executed via its Institute of Neurosciences and Department of Neurointerventional Radiology on 28th Oct'26. The interventions include a carotid artery stenting on a patient with ~90% stenosis using an Emboguard balloon guide catheter, flow diversion for a complex wide-neck cerebral aneurysm using the FLOWVIA Flow Diverter, and a transulnar artery stenting through wrist access for a high-risk comorbid patient. These successful procedures highlight the hospital's clinical capabilities in advanced endovascular care and stroke prevention.
We are pleased to inform you that Hannah Joseph Hospital Limited, has been awarded the "Honours for Healthcare Excellence in Neurosciences" at CII TN MedClave 2026, held on 24th October ....
Others (Uncategorized) · 26 Oct 2026, 8:11 pm
Hannah Joseph Hospital Wins Healthcare Excellence Award in Neurosciences Hannah Joseph Hospital Limited received the "Honours for Healthcare Excellence in Neurosciences" under the Above 100 Beds category in Tamil Nadu at the CII TN MedClave 2026, held on 24th Oct'26 in Chennai. Chairman and Managing Director Dr. Moses Joseph Arunkumar accepted the award on behalf of the company. The recognition highlights the hospital's multidisciplinary neuroscience offerings across neurology, neurosurgery, neuroanaesthesiology, interventional neuroradiology, neurorehabilitation, and neuropsychiatry.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Daniel Dayanand Fenn & PACs
Acquisition/ Disposal of Shares · 29 Sept 2026, 6:50 pm
Promoter Group Acquires Additional Equity Shares in Hannah Joseph Hospital Daniel Dayanand Fenn, belonging to the promoter group of Hannah Joseph Hospital Limited, acquired 2,000 equity shares (0.009% stake) via an open market transaction on 29th Sep'26. Following the acquisition, Fenn's direct shareholding increased from 12,015 shares (0.053%) to 14,015 shares (0.062%). Consequently, the aggregate promoter and PAC holding expanded from 1,62,28,400 equity shares (71.493%) to 1,62,30,400 equity shares (71.502%). The target company's total voting capital remains unchanged at Rs.22,69,83,630, comprising 2,26,98,363 equity shares of Rs.10 each.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Daniel Dayanand Fenn & PACs
Acquisition/ Disposal of Shares · 21 Sept 2026, 5:52 pm
Promoter Daniel Dayanand Fenn Acquires Additional Stake in Hannah Joseph Hospital Promoter Daniel Dayanand Fenn acquired 2,000 equity shares (0.009% stake) of Hannah Joseph Hospital Ltd. via open market on 18th Sep'26. Following the transaction, Fenn's direct holding increased from 10,015 shares (0.044%) to 12,015 shares (0.053%). Consequently, the combined promoter and PAC holding rose from 1,62,26,400 shares (71.484%) to 1,62,28,400 shares (71.493%). The company's total voting equity capital remains unchanged at Rs 22.70 cr, comprising 2,26,98,363 equity shares of Rs 10 each.
We are pleased to inform you that Hannah Joseph Hospital Limited has been recognized as the "Winner" in the category of "Best Healthcare Digital Initiative" at the 5th CII WR Health Innovation ....
Others (Uncategorized) · 09 Sept 2026, 11:48 pm
Hannah Joseph Hospital Wins CII Best Healthcare Digital Initiative Award Hannah Joseph Hospital Limited has won the "Best Healthcare Digital Initiative" award at the 5th CII WR Health Innovation Awards '26, organized by the Confederation of Indian Industry. The recognition was presented during the 9th edition of the CII Hospital Tech '26 summit, held on 8th–9th Sep'26 at Hotel Taj Lands End, Mumbai, acknowledging the company's continuous technology adoption and digital innovation to enhance healthcare service delivery.
We are pleased to inform you that Hannah Joseph Hospital Limited, Madurai has been conferred with the "AHPI-TN Excellence Award 2026 - Best Single Hospital above 100 beds - Central Zone" ....
Others (Uncategorized) · 01 Sept 2026, 5:47 pm
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Daniel Dayanand Fenn & PACs
Acquisition/ Disposal of Shares · 11 Aug 2026, 6:49 pm
Promoter Group Member Increases Stake in Hannah Joseph Hospital Promoter group member Daniel Dayanand Fenn acquired 2,000 equity shares (0.009% stake) of Hannah Joseph Hospital Limited via an open market transaction on 10 Aug'26. This acquisition increased his individual shareholding from 8,015 shares (0.035%) to 10,015 shares (0.044%). Consequently, the total promoter and PAC holding increased from 1,62,24,400 shares (71.475%) to 1,62,26,400 shares (71.484%), further consolidating the promoter group's position in the company.
Submission of Voting Results and Consolidated Scrutinizer''s report of the 15th Annual General Meeting of the Company.
Annual General Meeting · 16 Jul 2026, 11:45 pm
Proceedings of 15th Annual General Meeting of the Company.
Annual General Meeting · 16 Jul 2026, 2:54 am
Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 regarding recognition of Hannah Joseph Hospital in the Times Health Survey - All India Critical Care Hospital Ranking Survey 2026.
Press Release · 08 Jul 2026, 8:57 pm
Hannah Joseph Hospital Ranked No. 1 in Neuro Sciences in Madurai Hannah Joseph Hospital (HJHL) has been ranked No. 1 in Madurai for its Neuro Sciences division under the single-speciality category in the Times Health Survey 2026. The All India Critical Care Hospital Ranking Survey was published in The Times of India on 28th Jun'26. This recognition underscores the hospital's excellence in neurological care and is expected to enhance its brand value and strengthen its market position as a leading regional healthcare provider. The company intimated this development to the exchange on 08th Jul'26.
Submission of Annual Report for the Financial Year 2025-26 pursuant to Regulation 34 of the SEBI (LODR) Regulations, 2015
Others (Uncategorized) · 18 Jun 2026, 2:38 pm
Submission of Notice of the 15th Annual General Meeting of the Company scheduled to be held on July 15, 2026 through Video Conferencing (VC) / Other Audio-Visual Means (OAVM)
Annual General Meeting · 17 Jun 2026, 12:00 am
Investor Presentation under Regulation 30 read with schedule III of the SEBI (LODR) Regulations, 2015
Investor Presentation · 16 Jun 2026, 9:12 pm
Hannah Joseph Hospital Outlines Growth Trajectory and Oncology Expansion Plans Hannah Joseph Hospital, a 133-bed multi-specialty facility in Madurai, projects robust growth, forecasting revenue of ₹92.05 Cr and PAT of ₹11.18 Cr for FY26. This represents a 19% revenue CAGR from FY23-26. Key operational metrics are expected to improve, with ARPOB targeted to reach ₹1.39 Lakh and capacity utilization rising to 43% by FY26. A key strategic initiative includes expanding into a dedicated Radiation Oncology Centre, leveraging its core neurosciences expertise to drive high-margin revenue streams and enhance patient retention.
We wish to inform you that the Board of Directors of the Company, at its meeting held on today the 15th June, 2026, fixed Wednesday, July 08, 2026 as Cut-off date for determining the eligibility ....
Annual General Meeting · 15 Jun 2026, 8:01 pm
Hannah Joseph Hospital Announces FY26 Dividend and Record Date Hannah Joseph Hospital's board recommended a final dividend of ₹2 per equity share (20% on a ₹10 face value) for FY26, pending shareholder approval at the AGM on 15 Jul'26. The company has fixed 08 Jul'26 as the record date for determining dividend eligibility and the cut-off date for e-voting. The remote e-voting period is scheduled from 12 Jul'26 to 14 Jul'26. The dividend, if approved, will be paid within 30 days of the AGM declaration.
We wish to inform you that the Board of Directors of the Company, at its meeting held on today the 15th June, 2026 has fixed Wednesday, July 08, 2026 as the Record date for determining ....
Dividend · 15 Jun 2026, 7:42 pm
Hannah Joseph Hospital Announces Record Date for FY26 Final Dividend Hannah Joseph Hospital has declared a final dividend of ₹2 per equity share (20% on a ₹10 face value) for the financial year 2025-26, subject to shareholder approval. The company has set Jul 08, '26 as both the record date for dividend eligibility and the cut-off date for e-voting entitlement for its 15th Annual General Meeting. The AGM is scheduled for Jul 15, '26. The remote e-voting period will run from Jul 12, '26 to Jul 14, '26.
We wish to inform you that the 15th Annual General Meeting ("AGM") of the Company will be held on Wednesday, July 15, 2026 at 12:00 Noon (IST) through video conferencing ("VC")/Other Audio ....
Annual General Meeting · 15 Jun 2026, 7:29 pm
Hannah Joseph Hospital Announces FY26 Dividend, Sets Record Date Hannah Joseph Hospital has scheduled its 15th AGM for 15 Jul'26. The Board recommended a final dividend of ₹2 per equity share (20%) for FY26, subject to shareholder approval. The company has fixed 08 Jul'26 as the record date for determining dividend entitlement and the cut-off date for e-voting eligibility. The remote e-voting period is from 12 Jul'26 to 14 Jul'26. If approved, the dividend will be paid within 30 days of the AGM.
We wish to inform you that the Board of Directors of the Company at their meeting held on 29.05.2026 has recommended a final dividend of Rs.2/- per equity share of face value of Rs.10/- ....
Dividend · 29 May 2026, 8:44 pm
Hannah Joseph Hospital FY26 Results: Strong Profit Growth and Dividend Declared For FY26, Hannah Joseph Hospital reported a 55% YoY increase in profit after tax to ₹111.8M from ₹72.1M. Revenue from operations grew 18.7% YoY to ₹920.5M. The Board recommended a final dividend of ₹2.00 per share (20%) for the financial year ended 31 Mar'26, subject to shareholder approval. The company also confirmed no deviation in the utilization of its IPO proceeds and re-appointed M/s. Pandiarajan.T & Co. as internal auditors for FY27.
Re-Appointment of Internal Auditors for the Financial Year 2026-27
Change in Management · 29 May 2026, 8:13 pm
Hannah Joseph Hospital Re-appoints Internal Auditor for FY27 Hannah Joseph Hospital's Board of Directors has re-appointed M/s. Pandiarajan.T & Co., Chartered Accountants (Firm Reg. No. 014311S), as the company's internal auditor for the financial year 2026-27. The decision was made at the board meeting held on 29 May'26. M/s. Pandiarajan.T & Co. is a proprietorship firm with over 15 years of experience in audit, taxation, and financial advisory services.
Statement on deviation or variation for half year ended 31.03.2026
Others (Uncategorized) · 29 May 2026, 7:56 pm
Hannah Joseph Hospital Reports No Deviation in IPO Fund Utilization Hannah Joseph Hospital confirmed no deviation in utilizing its IPO proceeds for the half-year ended 31 Mar '26. The company raised ₹4,200 lakhs on 29 Jan '26, of which ₹753.29 lakhs has been utilized. A significant portion, ₹3,427.41 lakhs, earmarked for capital expenditure on a Radiation Oncology Centre remains unutilized. This balance is currently held in fixed deposits for future use. The board and audit committee reviewed the statement on 29 May '26.
Audited Financial Results for the Half year and year ended March 31, 2026
Financial Result · 29 May 2026, 7:23 pm
Hannah Joseph Hospital FY26 Results: Strong Profit Growth and Dividend Declared Hannah Joseph Hospital reported strong FY26 results with a Profit After Tax of ₹111.81 Cr, a 55.08% YoY increase from ₹72.10 Cr in FY25. Revenue from operations grew 18.73% YoY to ₹920.52 Cr. For H2'FY26, PAT stood at ₹60.63 Cr, up 94.25% YoY. Basic EPS for FY26 improved to ₹6.32 from ₹4.32. The board recommended a final dividend of ₹2.0 per share (20% of face value), subject to shareholder approval. The company confirms no deviation in the utilization of its IPO proceeds.
The Board of Directors of the Company at their meeting held on 29.05.2026, inter alia, approved the following: 1. Audited Financial Results for the half year and financial year ended 31st ....
Outcome · 29 May 2026, 7:06 pm
HANNAH - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakh) ■ Revenue: 4,951 (+33.8% YoY | +16.4% QoQ) ■ EBITDA: 1,344 (+43.5% YoY | +14.3% QoQ) ■ EBITDA Margin (%): 27.2 (+183 bps YoY | -48 bps QoQ) ■ PAT: 606 (+94.2% YoY | +18.4% QoQ) ■ EPS (INR): 3.43 (+83.4% YoY | +11.7% QoQ)
Hannah Joseph Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Revised Prior Intimation ....
Intimation · 29 May 2026, 5:30 am
Hannah Joseph Hospital Schedules Board Meeting for FY26 Results and Dividend Hannah Joseph Hospital (BSE: 544687) has scheduled a Board of Directors meeting on 29 May'26 to consider and approve its audited financial results for the half-year and full financial year ended 31 Mar'26. The board will also consider a recommendation for a final dividend for FY26. The trading window for designated persons has been closed since 01 Apr'26 and will reopen 48 hours after the results are declared. This is a revised intimation, following a previous notice on 18 May'26.
Hannah Joseph Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the Audited Financial ....
Intimation · 29 May 2026, 5:30 am
Hannah Joseph Hospital Board Meeting Set for May 29 to Approve FY26 Results Hannah Joseph Hospital (BSE: 544687) scheduled a Board of Directors meeting on 29 May'26 to consider and approve the audited financial results for the half-year and financial year ended 31 Mar'26. The trading window for insiders, which closed on 01 Apr'26, will remain shut until 48 hours after the results are declared.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Others (Uncategorized) · 27 Apr 2026, 11:36 pm
Hannah Joseph Hospital Confirms It Is Not a "Large Corporate" Under SEBI Rules Hannah Joseph Hospital (HANNAH) has informed the exchange that it does not qualify as a "Large Corporate" under the SEBI framework for the financial year ended Mar 31, '26. The company disclosed that its outstanding borrowings stood at ₹25.09 Cr as of that date. Consequently, the SEBI circular dated Oct 19, '23, regarding mandatory fundraising through debt securities, is not applicable to the company. The firm also stated it had no credit rating during the previous financial year.